Nivolumab Is a Cost-Effective Second-Line Treatment for Metastatic Renal-Cell Carcinoma.
| Image |  |
|---|---|
| Description | scientific article published on 22 February 2018 |
| Author/s |
author: Jacopo Giuliani |
| Publication date | February 22, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |